Bard Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Bard Associates's NVO Position: Q3 2026 in Review
Bard Associates opened a new position in Novo Nordisk (NVO) in Q3 2026: 100 shares worth $3.79K. The stake represents ﹤0.01% of the portfolio and ranks #299 among its holdings.
1,223 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Bard Associates held 100 shares of Novo Nordisk worth $3.79K as of Q3 2026.
- Novo Nordisk was a new Bard Associates position in Q3 2026.
- Novo Nordisk made up ﹤0.01% of Bard Associates's portfolio in Q3 2026, its #299 holding.
- 1,223 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Bard Associates's 13F filing for Q3 2026, filed 13 Nov 2026.